Antidiabetic principles of natural medicines. V. Aldose reductase inhibitors from Myrcia multiflora DC. (2): Structures of myrciacitrins III, IV, and V

Chemical and Pharmaceutical Bulletin

Volumn 50, Issue 3, 2002, Pages 429-431

  Matsuda, Hisashi ^a   Nishida, Norihisa ^a   Yoshikawa, Masayuki ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Acylated flavanone glucoside; Aldose reductase inhibitor; Flavanone glucoside; Myrcia multiflora; Myrciacitrin

Indexed keywords

ALDOSE REDUCTASE INHIBITOR; ANTIDIABETIC AGENT; FLAVANONE DERIVATIVE; MYRCIA MULTIFLORA EXTRACT; MYRCIACITRIN I; MYRCIACITRIN II; MYRCIACITRIN III; MYRCIACITRIN IV; MYRCIACITRIN V; MYRCIAPHENONE A; MYRCIAPHENONE B; PLANT EXTRACT; UNCLASSIFIED DRUG; ALDEHYDE REDUCTASE; ENZYME INHIBITOR; FLAVONOID;

ARTICLE; DRUG ACTIVITY; DRUG ISOLATION; DRUG POTENCY; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; MEDICINAL PLANT; MYRCIA MULTIFLORA; PHYSICAL CHEMISTRY; PLANT LEAF; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; MYRICACEAE;

ALDEHYDE REDUCTASE; ENZYME INHIBITORS; FLAVONOIDS; HYPOGLYCEMIC AGENTS; MOLECULAR STRUCTURE; MYRICACEAE; PLANT LEAVES;

EID: 0036511915     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.50.429     Document Type: Article

References (9)

1. Part IV: Matsuda H., Murakami T., Yashiro K., Yamahara J., Yoshikawa M., Chem. Pharm. Bull., 47, 1725-1729 (1999).
2. a) Yoshikawa M., Murakami T., Kishi A., Kageura T., Matsuda H., Chem. Pharm. Bull., 49, 863-870 (2001);
3. b) Yoshikawa M., Nishida N., Shimoda H., Takada M., Kawahara Y., Matsuda H., Yakugaku Zasshi, 121, 371-378 (2001);
4. c) Matsuda H., Morikawa T., Ueda H., Yoshikawa M., Heterocycles, 55, 1499-1504 (2001).
5. Yoshikawa M., Shimada H., Nishida N., Li Y., Toguchida I., Yamahara J., Matsuda H., Chem. Pharm. Bull., 46, 113-119 (1998).
6. Mimaki Y., Watanabe K., Ando Y., Sakuma C., Sashida Y., Furuya S., Sakagami H., J. Nat. Prod., 64, 17-22 (2001).
7. 13C COSY), and heteronuclear multiple-bond connectivity (HMBC) experiments.
8. Gaffield W., Tetrahedron, 26, 4093-4108 (1970).
9. Terashima H., Hama K., Yamamoto R., Tsuboshima M., Kikkawa R., Hatanaka I., Shigeta Y., J. Pharmacol. Exp. Ther., 229, 226-230 (1984).